Blog

Valsartan Roundup: Links Between the Drug and Liver Damage

December 30, 2019 | Firm News

The Food and Drug Administration (FDA) has issued a recall of Valsartan after finding batches of the drug were contaminated with N-nitrosodimethylamine (NDMA). Valsartan is a popular drug used to treat high blood pressure or heart failure and a generic form of Diovan. The drug, in and of itself, can cause liver damage. However, NDMA… read more

What Are the Differences Between TDF and TAF?

December 22, 2019 | Firm News,Mass Torts

Tenofovir disoproxil fumarate (TDF) is an antiretroviral (ARV) medication approved in 2001 to prevent and treat HIV, and in 2008 to treat chronic hepatitis B. Tenofovir alafenamide (TAF) is a new and improved formulation of tenofovir, approved in 2015. Although TDF is the most commonly prescribed ARV, it presents several safety concerns. What is TDF… read more

Massachusetts Government Issues Statewide Ban on Vaping: National Trend or Not?

December 13, 2019 | Firm News

Public health officials are scrambling for a solution to a recent epidemic involving vaping-related injuries. In November, Massachusetts became the first state to pass a law banning the sale of flavored tobacco and vaping products. As many other states have similar legislation pending, it leaves many wondering whether bans on vaping will become a national… read more